Evidence map›Paper›PMID 31506309›Full record

ArticlemBio2019

Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.

Henju Marjuki, Nadav Topaz, Sandeep J Joseph, Kim M Gernert, Ellen N Kersh, Antimicrobial-Resistant Neisseria gonorrhoeae Working Group, Xin Wang

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Discovery and characterization of an anti-Frontiers in microbiology · 2026
    Article
  7. Frontiers in microbiology · 2026
    Review
  8. Observational
  9. Article
  10. Effectiveness of the four-component protein-based meningococcal vaccine againstCanada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trends.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  15. Article
  16. PreclinicalFrontiers in immunology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Henju MarjukiMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nadav TopazMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sandeep J JosephMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, IHRC, Inc., Atlanta, Georgia, USA.
Kim M GernertLaboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ellen N KershLaboratory Reference and Research Branch, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Antimicrobial-Resistant Neisseria gonorrhoeae Working Group
Xin WangMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA gqe8@cdc.gov.
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human pathogens

Indexed as

Adhesins, BacterialAmino Acid SequenceBacterial Outer Membrane ProteinsBacterial VaccinesBase SequenceCross ProtectionGonorrheaHumansMembrane ProteinsMeningococcal InfectionsMeningococcal VaccinesNeisseria gonorrhoeaeNeisseria meningitidisNeisseria meningitidis, Serogroup BNew ZealandPhylogenyAdhesins, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesMembrane ProteinsMeningococcal VaccinesNadA protein, Neisseria meningitidisporin protein, NeisseriaPorinsBexserocross-protectiongenetic similarityMenB-4CNeisseria gonorrhoeaeNeisseria meningitidisouter membrane proteinsouter membrane vesiclesvaccine development

Identifiers

PMID31506309
PMCPMC6737241
OpenAlexW2972475403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.